Impact of circulating tumor DNA mutant allele fraction on prognosis in RAS‐mutant metastatic colorectal cancer

Despite major advances in the treatment of metastatic colorectal cancer (mCRC), the survival rate remains very poor. This study aims at exploring the prognostic value of RAS‐mutant allele fraction (MAF) in plasma in mCRC. Forty‐seven plasma samples from 37 RAS‐mutated patients with nonresectable met...

Descripción completa

Detalles Bibliográficos
Autores principales: Elez, Elena, Chianese, Chiara, Sanz‐García, Enrique, Martinelli, Erica, Noguerido, Alba, Mancuso, Francesco Mattia, Caratù, Ginevra, Matito, Judit, Grasselli, Julieta, Cardone, Claudia, Esposito Abate, Riziero, Martini, Giulia, Santos, Cristina, Macarulla, Teresa, Argilés, Guillem, Capdevila, Jaume, Garcia, Ariadna, Mulet, Nuria, Maiello, Evaristo, Normanno, Nicola, Jones, Frederick, Tabernero, Josep, Ciardello, Fortunato, Salazar, Ramon, Vivancos, Ana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Research Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717744/
https://www.ncbi.nlm.nih.gov/pubmed/31322322
http://dx.doi.org/10.1002/1878-0261.12547

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6717744/
https://www.ncbi.nlm.nih.gov/pubmed/31322322
http://dx.doi.org/10.1002/1878-0261.12547

Ejemplares similares